After 40 Years, Heart Doctors Say Beta Blockers May Do More Harm Than Good
A groundbreaking international trial has found beta blockers don’t help most heart attack patients with preserved heart function,…
Salt substitute use remains low among Americans with high blood pressure
Few people with high blood pressure were using salt substitutes, even though they are a simple and effective…
7 Pulmonology Headlines You Missed in August 2025
August 2025 brought several significant updates in pulmonology, spanning advances in early detection, disease-modifying therapies, and clinical guidance.…
Semaglutide Shows Safety in Patients with Schizophrenia, Prediabetes, Obesity
Ashok A. Ganeshalingam, MD Credit: LinkedIn A recent study showed that 30 weeks of semaglutide administration, up to…
Trial compares the use of blood thinners after stenting in patients with acute coronary syndromes
Sep 3 2025 Noninferiority was not demonstrated for death and ischemic events between P2Y12 inhibitor monotherapy and dual…
Reconditioned pacemakers show comparable infection rates to new devices
Procedure-related infection rates were similar with reconditioned and new pacemakers, according to late-breaking research presented in a Hot…
Cardiovascular screening in men aged 60 to 64 years does not reduce all-cause mortality
An invitation to attend a comprehensive screening examination for the early signs of cardiovascular disease (CVD) did not…
Revascularization strategy fails to show noninferiority in STEMI patients
Noninferiority was not demonstrated between immediate and staged complete revascularisation in patients with ST-segment elevation myocardial infarction (STEMI)…
Artificial intelligence offers individualized anticoagulation decisions for atrial fibrillation
Bottom Line: Mount Sinai researchers developed an AI model to make individualized treatment recommendations for atrial fibrillation (AF)…
Adding aspirin raises cardiovascular events in high-risk CCS patients on anticoagulants
Adding aspirin increased the risk of cardiovascular events, death and major bleeding in high-risk patients with chronic coronary…
Ivabradine fails to prevent myocardial injury after noncardiac surgery in large clinical trial
Ivabradine did not reduce the occurrence of myocardial injury after noncardiac surgery (MINS), according to late-breaking research presented…
Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors
Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major…